Age-related adverse drug reactions to clomipramine

Acta Psychiatrica Scandinavica

Volumn 105, Issue 1, 2002, Pages 55-59

  Stage, K B ^a,b   Bech, P ^c   Kragh Sorensen P ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

Author keywords

Clomipramine; Major depression; Orthostatic hypotension; Side effects

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACCOMMODATION PARALYSIS; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DEPRESSION; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RISK FACTOR; SEDATION; SWEATING; TREMOR; VERTIGO; XEROSTOMIA;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIDDLE AGED;

EID: 0036173837     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2002.0_001.x     Document Type: Article

References (35)

1. The kinetics of amitryptyline following single oral dose administration to man
2. Nortriptyline in depressed patients with high plasma levels (II)
3. Pharmacokinetics of amitryptyline in the elderly
4. Amitriptyline disposition in young and elderly normal men
5. Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers
6. Relationship between age and tricyclic antidepressant plasma levels
7. Single-dose kinetics predict steady state concentrations of imipramine and desipramine
8. Comparison of singledose pharmacokinetics of imipramine and maprotiline in the elderly
9. High serum concentrations of antidepressants in elderly patients
10. Effects of age, cigerette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite druing chronic dosing
11. Plasma levels of monomethylated tricyclic antidepressants during treatment with imipraminelike compounds
12. Plasma level monitoring of tricyclic antidepressant therapy
13. Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism
14. Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants
15. Clinical characteristics of imipramine-induced orthostatic hypotension
16. Cardiovascular effect of imipramine and nortriptyline in elderly patients
17. Mianserin: Cardiovascular effects in elderly patients
18. Effect of antidepressant drugs on serotonergic and adrenergic receptors
19. Effects of antidepressant drugs on different receptors in the brain
20. Orthostatic side effects of clomipramine and citalopram during treatment for depression
21. Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients
22. Psychotropic drug use and the risk of hip fracture
23. Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
24. Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study
25. Moclobemide: A reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study
26. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients
27. Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo
28. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia
29. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients
30. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people
31. Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: A meaningful difference
32. Single oral dose pharmacokinetics of clomipramine in depressed patients
33. Drug level monitoring in psychopharmacology: Usefulness and clinical problems, with special reference to tricyclic antidepressants
34. Tricyclic antidepressants - Blood level measurement and clinical outcome: An APA task force report
35. Depressed patients with cardiovascular disease: Treatment considerations